LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 19.69 | 84.90 | 1298 | 1239 | 1.0473 | 1.0240 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 19.69 | 84.90 | 1393 | 1239 | 1.1239 | 1.0613 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 19.69 | 84.90 | 1113 | 1239 | 0.8980 | 0.9451 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 19.69 | 84.90 | 1475 | 1239 | 1.1901 | 1.0920 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 19.69 | 84.90 | 8 | 1239 | 0.0065 | -0.4570 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 19.69 | 84.90 | 1269 | 1239 | 1.0239 | 1.0122 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 19.69 | 84.90 | 7 | 1239 | 0.0056 | -0.4754 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 19.69 | 84.90 | 1360 | 1239 | 1.0973 | 1.0486 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 21.40 | 84.90 | 1446 | 1454 | 0.9940 | 0.9971 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 21.40 | 84.90 | 1527 | 1454 | 1.0497 | 1.0238 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 21.40 | 84.90 | 1450 | 1454 | 0.9968 | 0.9984 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 21.40 | 84.90 | 1613 | 1454 | 1.1088 | 1.0511 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 21.40 | 84.90 | 17 | 1454 | 0.0117 | -0.3245 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 21.40 | 84.90 | 1377 | 1454 | 0.9466 | 0.9734 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 21.40 | 84.90 | 10 | 1454 | 0.0069 | -0.4066 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 21.40 | 84.90 | 1481 | 1454 | 1.0181 | 1.0088 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 23.10 | 84.90 | 1653 | 1616 | 1.0228 | 1.0106 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 23.10 | 84.90 | 1699 | 1616 | 1.0512 | 1.0236 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 23.10 | 84.90 | 1608 | 1616 | 0.9949 | 0.9976 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 23.10 | 84.90 | 1731 | 1616 | 1.0710 | 1.0325 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 23.10 | 84.90 | 19 | 1616 | 0.0118 | -0.2968 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 23.10 | 84.90 | 1442 | 1616 | 0.8922 | 0.9471 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 23.10 | 84.90 | 18 | 1616 | 0.0111 | -0.3057 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 23.10 | 84.90 | 1593 | 1616 | 0.9856 | 0.9932 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.81 | 84.90 | 1760 | 1769 | 0.9946 | 0.9975 | MN20160318_Q02 | D03 |